sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
LGND
Updated 10/6/2026, 6:18 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | Sale | $1,520,346 | Reardon Andrew CLO & Secretary | 5,000 sh | at $304.07 | Filed Oct 6, 4:35 PM ET | Filing | |
| LGND LIGAND PHARMACEUTICALS INC | Sale | $342,000 | Zimmermann Martine Director | 1,200 sh | at $285.00 | Filed Sep 14, 4:59 PM ET | Filing | |
| LGND LIGAND PHARMACEUTICALS INC | Sale | $1,430,434 | Reardon Andrew CLO & Secretary | 5,000 sh | at $286.09 | Filed Sep 8, 6:34 PM ET | Filing | |
| LGND LIGAND PHARMACEUTICALS INC | Sale | $9,241,229 | Espinoza Octavio Chief Financial Officer | 31,641 sh | at $292.07 | Filed Aug 14, 5:05 PM ET | Filing | |
| LGND LIGAND PHARMACEUTICALS INC | Sale | $2,090,062 | Haas Jason Director | 7,138 sh | at $292.81 | Filed Aug 14, 5:04 PM ET | Filing | |
| LGND LIGAND PHARMACEUTICALS INC | Sale | $1,444,951 | Reardon Andrew CLO & Secretary | 5,000 sh | at $288.99 | Filed Aug 4, 6:42 PM ET | Filing |